Finsbury Worldwide Pharm Tst PLC
14 June 2006
14 June 2006
FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
(the 'Company')
ANNUAL INFORMATION UPDATE
For the 12 months ending Wednesday, 14 June 2006
In accordance with the Prospectus Rule 5.2, the Company hereby announces that
the following summaries have been made available to the public within the 12
months ending on 14 June 2006.
In respect of Article 27.3 of the Prospectus Directive, the Company confirms
that the information relating to the Company referred to below was at the time
of publication accurate and up-to-date, it is acknowledged however that some
information may have since been superseded and therefore be out-of-date at the
time of this Annual Information Update.
Date of Publication Summary Description Method of Publication
13 June 2006 Annual Report & Accounts to 31 March 2006 Post and Website
31 May 2006 Final Results RNS
12 May 2006 Holdings in Company RNS
19 April 2006 Holdings in Company RNS
19 April 2006 Issue of Equity RNS
19 April 2006 Blocklisting RNS
12 April 2006 Director/PDMR Shareholding RNS
12 April 2006 Director/PDMR Shareholding RNS
4 April 2006 EGM Special Business Resolutions Companies House
4 April 2006 Portfolio Update RNS
29 March 2006 Result of EGM RNS
9 March 2006 Holdings in Company RNS
6 March 2006 Holdings in Company RNS
28 February 2006 Annual Return Companies House
27 February 2006 Issue of Equity RNS
27 February 2006 Additional Listing RNS
7 February 2006 Holdings in Company RNS
27 January 2006 Holdings in Company RNS
26 January 2006 Holdings in Company RNS
25 January 2006 Holdings in Company RNS
23 January 2006 Director/PDMR Shareholding RNS
18 January 2006 Issue of Equity RNS
18 January 2006 Issue of Equity RNS
16 January 2006 Holdings in Company RNS
13 January 2006 Holdings in Company RNS
11 January 2006 Issue of Equity RNS
11 January 2006 Issue of Equity RNS
10 January 2006 Holdings in Company RNS
5 January 2006 Blocklisting Interim Review RNS
4 January 2006 Issue of Equity RNS
4 January 2006 Portfolio Update RNS
4 January 2006 Director/PDMR Shareholding RNS
3 January 2006 Issue of Equity RNS
28 December 2005 Holdings in Company RNS
13 December 2005 Holdings in Company RNS
9 December 2005 Issue of Equity RNS
8 December 2005 Holdings in Company RNS
6 December 2005 Issue of Equity RNS
1 December 2005 Issue of Equity RNS
23 November 2005 Issue of Equity RNS
22 November 2005 Issue of Equity RNS
22 November 2005 Issue of Equity RNS
15 November 2005 Interim Results RNS
10 November 2005 Director/PDMR Shareholding RNS
7 November 2005 Director Declaration RNS
4 November 2005 Issue of Equity RNS
2 November 2005 Issue of Equity RNS
31 October 2005 Issue of Equity RNS
24 October 2005 Holdings in Company RNS
18 October 2005 Issue of Equity RNS
14 October 2005 Issue of Equity RNS
11 October 2005 Issue of Equity RNS
5 October 2005 Director/PDMR Shareholding RNS
4 October 2005 Portfolio Update RNS
1 September 2005 Holdings in Company RNS
26 August 2005 Holdings in Company RNS
8 August 2005 AGM Special Business Resolutions Companies House
4 August 2005 Annual Report & Accounts to 31 March 2005 Companies House
2 August 2005 Exercise of Warrants RNS
28 July 2005 AGM Statement RNS
28 July 2005 Holdings in Company RNS
5 July 2005 Portfolio Update RNS
30 June 2005 Additional Listing RNS
1 June 2005 Final Results RNS
23 May 2005 Holdings in Company RNS
22 April 2005 Holdings in Company RNS
13 April 2005 Annual Return Companies House
4 April 2005 Portfolio Update RNS
In addition to the above items, the Company announces its net asset value on a
daily basis via RNS.
RNS
The information detailed above publicised via method RNS, the Company's
preferred Regulatory Information Service, may be obtained from the Regulatory
News Service provided by the London Stock Exchange at
www.londonstockexchange.co.uk/marketnews.
Companies House
The information detailed above publicised via method Companies House, may be
obtained from Companies House, Crown Way, Cardiff CF14 3UZ, or via Companies
House Direct at www.direct.companieshouse.gov.uk.
Close Finsbury Asset Management Limited (Close Finsbury)
Close Finsbury is the appointed Corporate Company Secretary of the Company; as
such copies of all of the above publications can be obtained or viewed on
request to the Company Secretary, Finsbury Worldwide Pharmaceutical Trust PLC,
10 Crown Place, London, EC2A 4FT.
Close Finsbury manages a website www.closefinsbury.com where information,
including copies of the Interim and Annual Reports and a monthly factsheet, of
the Company may also be viewed or downloaded.
Further information may be obtained from:
Mark Pope
Company Secretary
Close Finsbury Asset Management Limited
Tel. 020 7426 6294
Fax. 020 7247 4722
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.